The company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Novavax applies for FDA nod for its updated COVID vaccine
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Genetic vulnerability, air pollution may raise risk of COVID infection, severe outcomes
- COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal
- Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
- US flu season shows signs of peak